(Q38203324)

30 August 2017

title

Management and treatment of chronic hepatitis B in HIV-positive patients (English)

1 reference

30 August 2017

1 reference

1 reference

1

Vincent Soriano

1 reference

30 August 2017

Carmen de Mendoza

2

1 reference

30 August 2017

José V Fernández-Montero

series ordinal

3

1 reference

30 August 2017

Pablo Labarga

series ordinal

4

1 reference

30 August 2017

Pablo Barreiro

series ordinal

5

1 reference

30 August 2017

language of work or name

English

0 references

publication date

10 April 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

46

1 reference

30 August 2017

issue

5

1 reference

30 August 2017

page(s)

290-296

1 reference

Epidemiology of hepatitis B and C viruses: a global overview

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Hepatitis B and human immunodeficiency virus coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Diagnosis and personalized management of hepatitis B including significance of genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Recurrence of another hepatitis B virus escape mutant comes back in a patient infected with HIV and low CD4+ count

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Spontaneous reactivation of hepatitis B virus replication in an HIV coinfected patient with isolated anti-Hepatitis B core antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Natural history of chronic hepatitis B in co-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Hepatitis B and long-term HIV outcomes in coinfected HAART recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

The HBV drug entecavir - effects on HIV-1 replication and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Genotypic determinants and phenotypic properties of antiviral-resistant HBV variants: insight from entecavir resistance studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Hepatitis B virus escape mutants induced by antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Primary infection with a lamivudine-resistant hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Mutations in HBV DNA polymerase associated with nucleos(t)ide resistance are rare in treatment-naive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Acute hepatitis B infection associated with drug-resistant hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Strategic use of lamivudine in the management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Hepatitis delta in HIV-infected individuals in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Hepatitis delta and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Clinical features of hepatitis D.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Treatment of chronic delta hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

Liver transplantation in delta virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

HIV–HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2014.899103

10.3109/07853890.2014.899103

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference